Press-release for stocks for teva pharmaceutical industries ltd

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Teva pharmaceutical industries ltd crawled time : 05:00

save search

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | News | $0.0007 -50.0% 1K

|

| 471.43% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K

|

Health Technology

| -6.19% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | News | $94.25 -2.18% 480

|

Health Technology

| 0.61% | O: -1.64% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

|

Health Technology

| -3.24% | O: -0.34% H: 0.0% C: -1.2%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| -4.45% | O: -1.57% H: 0.26% C: -0.47%
GSK | News | $40.86 -0.92% -0.15% 1.7M

|

Health Technology

| -1.86% | O: -0.48% H: 0.16% C: 0.0%
BAX | $40.93 -0.22% 0.0% 2.2M

|

Health Technology

| 4.16% | O: -0.96% H: 5.91% C: 3.74%
ABT | News | $106.89 -0.65% -0.22% 5.1M

|

Health Technology

| -6.02% | O: -1.41% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -0.19% | O: -2.25% H: 0.0% C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

|

Health Technology

| -7.55% | O: 0.38% H: 0.34% C: -0.72%
america growth market

Nontuberculous Mycobacterial Infections Market size to grow by USD 4.33 billion from 2023 to 2028, North America to account for 40% of market growth- Technavio
Published: 2024-01-10 (Crawled : 05:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K

|

| -21.2% | O: 1.19% H: 0.2% C: 0.03%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

|

Health Technology

| -2.07% | O: -0.09% H: 7.77% C: 4.4%
ABT | News | $106.89 -0.65% -0.22% 5.1M

|

Health Technology

| -4.16% | O: 0.76% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -9.34% | O: 0.13% H: 0.0% C: 0.0%
america infections market

Topical Corticosteroids Market to grow by USD 1.09 billion from 2022-2027, Asia to account for 31% of market growth - Technavio
Published: 2023-10-11 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

|

Health Technology

| 4.52% | O: -1.75% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K

|

Health Technology

| 4.41% | O: 0.07% H: 0.0% C: -0.38%
NVSEF | News | $96.0 6.88% 52K

|

Health Technology

| -2.36% | O: 0.03% H: 0.0% C: -0.23%
ALPMY | News | $9.49 -1.11% 480K

|

| -31.06% | O: -3.81% H: 5.97% C: 2.57%
VTRS | News A | $11.55 1.67% 1.65% 7.2M

|

Health Technology

| 18.09% | O: 0.0% H: 1.3% C: 0.73%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| 0.4% | O: 1.03% H: 0.03% C: -0.07%
GSK | News | $40.86 -0.92% -0.15% 1.7M

|

Health Technology

| 10.44% | O: 0.72% H: 0.24% C: -0.13%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

|

Health Technology

| 13.49% | O: -0.08% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -13.25% | O: 1.1% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

|

Health Technology

| 4.18% | O: -0.31% H: 0.34% C: 0.31%
asia growth market

Press Release: Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
Published: 2023-10-04 (Crawled : 05:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -11.71% | O: 1.07% H: 0.0% C: 0.0%
disease treatment collaboration teva sanofi

Onychomycosis Treatment Market size to grow by USD 1,776.53 million from 2022 to 2027; Growth driven by increasing prevalence of onychomycosis - Technavio
Published: 2023-08-15 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

|

Health Technology

| -11.29% | O: -2.02% H: 0.0% C: -1.05%
ALPMY | News | $9.49 -1.11% 480K

|

| -38.3% | O: 0.78% H: 0.39% C: -2.39%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| -4.36% | O: -0.32% H: 0.18% C: -0.44%
GSK | News | $40.86 -0.92% -0.15% 1.7M

|

Health Technology

| 16.37% | O: -0.51% H: 0.24% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -11.26% | O: 0.36% H: 0.0% C: 0.0%
treatment growth market

Heparin Market size is set to grow by USD 3,009.44 million from 2022 to 2027|Growing prevalence of chronic conditions boosts the market- Technavio
Published: 2023-07-12 (Crawled : 05:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M

|

Health Technology

| 10.83% | O: 0.98% H: 0.97% C: -1.06%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| 1.75% | O: 0.29% H: 0.49% C: 0.26%
BAX | $40.93 -0.22% 0.0% 2.2M

|

Health Technology

| -10.88% | O: 0.96% H: 0.52% C: -0.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -9.31% | O: -0.89% H: 0.0% C: 0.0%
set market

Cancer supportive care market to grow at a CAGR of 4.62% by 2027; North America to account for 39% of market growth - Technavio
Published: 2023-02-20 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K

|

Health Technology

| Email alert Add to watchlist
BAX | $40.93 -0.22% 0.0% 2.2M

|

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

|

Health Technology

| Email alert Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M

|

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M

|

Health Technology

| Email alert Add to watchlist
RLFTY | $1.4006 733.33% 100

|

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K

|

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480

|

Health Technology

| Email alert Add to watchlist
RLFTF | $1.45 11.45% 1.3K

|

| Email alert Add to watchlist
america care cancer growth market

Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
Published: 2022-11-16 (Crawled : 05:00) - globenewswire.com
ALVO | $13.5 0.75% 0.74% 190K

|

| 132.64% | O: -0.35% H: 5.4% C: 4.7%
KMDA | $5.16 1.18% 1.16% 11K

|

Health Technology

| 15.33% | O: 0.0% H: 1.56% C: -0.22%
financial update

Second Dupixent® (dupilumab) Phase 3 Eosinophilic Esophagitis Trial to Demonstrate Significant Disease Improvements, Underscoring Role of Type 2 Inflammation in This Complex Disease
Published: 2021-10-25 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

|

Health Technology

| -3.34% | O: 1.02% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -4.76% | O: 0.89% H: 0.26% C: -0.12%
REGN | News | $906.55 -0.09% -0.08% 370K

|

Health Technology

| 58.76% | O: 0.38% H: 0.88% C: 0.44%
disease phase 3 trial dupixent

New REGEN-COV™ (casirivimab and imdevimab) Data Show Supportive Results in Patients Hospitalized with COVID-19
Published: 2021-09-30 (Crawled : 05:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -2.71% | O: -0.02% H: 0.2% C: -0.31%
REGN | News | $906.55 -0.09% -0.08% 370K

|

Health Technology

| 49.55% | O: 0.17% H: 0.96% C: -0.42%
covid results casirivimab covid-19

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M

|

Consumer Services

BOF | $1.99 70.09% 41.21% 110M

|

ILAG | $0.51 6.03% 40.62% 1.7M

|

LICN | $0.941 68.04% 40.49% 15M

|

AMST | $3.31 65.5% 39.58% 70M

|

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M

|

Technology Services

WIMI | $1.15 58.53% 36.92% 19M

|

Technology Services

AIH | $0.45 12.5% 30.92% 320K

|

Health Services

MULN | News | $3.78 38.46% 27.78% 13M

|

RILY | $29.86 37.48% 27.26% 12M

|

Your saved searches

Save your searches and get alerts when important news are released.